Hyaluronic Acid Sodium Salt: ECM Biopolymer in Immune Modulation

Executive Summary: Hyaluronic acid sodium salt (sodium hyaluronate) is a high-molecular-weight glycosaminoglycan fundamental to the extracellular matrix (ECM) structure and function (see APExBIO product B8382). It is synthesized at the plasma membrane and regulates cell proliferation, migration, and adhesion. As a joint lubrication biopolymer, it provides viscoelasticity and shock absorption in synovial fluid. Recent research demonstrates that hyaluronic acid sodium salt-coated nanoparticles enable targeted siRNA delivery against TDRD9, promoting neutrophil cuproptosis and reducing Pseudomonas aeruginosa lung injury in preclinical models (Nature Communications, 2026). These properties make sodium hyaluronate a crucial tool for both ECM modeling and advanced therapeutic delivery platforms.

Biological Rationale

Hyaluronic acid sodium salt is a large, linear, nonsulfated glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. It is a major ECM component distributed in connective, epithelial, and neural tissues, accounting for the viscoelastic properties of synovial fluid and vitreous humor (APExBIO). Its functions extend beyond structural support, encompassing regulation of cell adhesion, proliferation, and migration—key aspects of tissue remodeling, wound repair, and embryonic development. Elevated sodium hyaluronate concentrations are linked to increased tumor cell invasiveness and angiogenesis in various cancer microenvironments (Nature Communications, 2026). The biopolymer’s high molecular weight (1,000–1,500 kDa for B8382) confers unique biophysical properties, enabling use in cell-based assays and as a carrier in drug delivery research.

Mechanism of Action of Hyaluronic acid sodium salt

Sodium hyaluronate’s primary mechanisms involve its role as an extracellular matrix component and as a modulator of cellular signaling. The molecule binds to cell-surface receptors such as CD44 and RHAMM, influencing pathways like PI3K-Akt and p38 MAPK. ECM-bound hyaluronic acid facilitates localization of matrix proteases (e.g., MMP-9), modulating tissue remodeling and cell motility. In the context of nanoparticle drug delivery, hyaluronic acid sodium salt enhances cellular uptake and targeting due to its affinity for CD44-expressing cells. Specifically, in recent studies, hyaluronic acid-coated nanoparticles successfully delivered siRNA targeting TDRD9 to neutrophils, promoting cuproptosis—a form of copper-dependent cell death—and reducing Pseudomonas aeruginosa-induced lung injury (Nature Communications, 2026). This highlights the dual role of sodium hyaluronate as a shock absorption polymer and as a PI3K-Akt signaling modulator in immune regulation.

Evidence & Benchmarks

• Hyaluronic acid sodium salt is insoluble in ethanol, water, and DMSO; optimal storage is at -20°C, and long-term storage of solutions is not recommended (APExBIO product info).
• HA-coated peptide nanoparticles successfully delivered siRNA targeting TDRD9 to neutrophils, reducing inflammation, edema, and bacterial load in preclinical Pseudomonas aeruginosa lung injury models (Nature Communications, 2026).
• Adoptive transfer of TDRD9-silenced neutrophils into neutrophil-depleted mice attenuated lung inflammation and neutrophil accumulation (Nature Communications, 2026).
• HA-siRNA nanoparticles modulate PD-L1/CD80/p38 MAPK signaling in neutrophils, promoting cuproptosis and enhancing bacterial clearance (Nature Communications, 2026).
• In vitro, biological effects of sodium hyaluronate are observed at nanomolar to micromolar concentrations, dependent on molecular weight and cell type (APExBIO).

This article extends findings from "HA-SiRNA Nanoparticles Target TDRD9 to Reduce P. aeruginosa Lung Injury" by detailing the ECM and signaling functions of sodium hyaluronate, whereas the cited internal article focused primarily on therapeutic outcomes. It also clarifies and updates data discussed in "siRNA Nanoparticles Target TDRD9 to Alleviate P. aeruginosa Lung Injury", providing additional molecular mechanism context.

Applications, Limits & Misconceptions

Sodium hyaluronate (hyaluronic acid sodium salt) is widely used in:

• Extracellular matrix modeling for tissue engineering and regenerative medicine.
• Drug delivery research, especially as a carrier for small molecules and nucleic acids targeting CD44+ cells.
• Cell-based assays for studying cell migration, adhesion, and proliferation.
• Immune modulation studies, particularly in the context of neutrophil function and inflammatory lung injury (Nature Communications, 2026).

However, its application has boundaries. Sodium hyaluronate is not a direct antimicrobial; its benefits in infection models depend on its role as a carrier or modulator, not as a bactericidal agent. Its viscoelastic and lubricating properties are not replicated in low-molecular-weight or chemically modified forms. Long-term solution storage is discouraged due to potential degradation (APExBIO).

Common Pitfalls or Misconceptions

• Sodium hyaluronate does not have intrinsic antibacterial activity; its role in infection models is as a carrier or signaling modulator, not as a direct bactericidal agent.
• Low-molecular-weight or degraded hyaluronic acid does not confer the same viscoelastic or ECM-mimetic functions as high molecular weight forms.
• Hyaluronic acid sodium salt is not a suitable substitute for other sulfated glycosaminoglycans in signaling or matrix remodeling studies.
• Improper storage (e.g., repeated freeze-thaw cycles) can lead to loss of molecular weight and function.
• Overinterpretation of in vitro effects without in vivo validation can misrepresent biological relevance.

Workflow Integration & Parameters

Protocol Parameters

• Reconstitution: Dissolve hyaluronic acid sodium salt in sterile physiological buffer (e.g., PBS, pH 7.2–7.4) at desired concentration (e.g., 1–10 mg/mL); vortex until fully dispersed.
• Nanoparticle coating: For siRNA delivery, mix with cationic peptides and siRNA at a mass ratio optimized for target cell uptake (typically 5:1:1 peptide:HA:siRNA) as described in preclinical protocols.
• Concentration for cell assays: Use at 10–100 µg/mL for ECM modeling or 100 nM–10 µM for cell signaling studies, referencing molecular weight and experimental context (APExBIO).
• Storage: Keep solid product at -20°C; do not store working solutions long-term.
• Endotoxin removal: For sensitive immune assays, pre-treat with endotoxin removal resin per manufacturer guidelines.

The above values are based on published literature and manufacturer recommendations; always adjust for specific cell types and assay formats.

Conclusion & Outlook

Hyaluronic acid sodium salt is a multifunctional biopolymer with established roles in ECM structure, cell signaling, and immune cell modulation. Its emerging use as a nanoparticle coating for siRNA delivery, especially in Pseudomonas aeruginosa lung injury models, marks a significant advance in translational research and immune therapeutics (Nature Communications, 2026). As demonstrated by APExBIO’s B8382 sodium hyaluronate, high molecular weight and purity are critical for reproducible results in both in vitro and in vivo systems. Future research will determine the extent to which ECM-inspired delivery platforms can be generalized to other models of inflammation and tissue injury, but current benchmarks support its adoption in advanced immune modulation studies.